The FDA is “getting real traction” in its efforts to use real-world evidence to support agency regulatory decisions, an FDA deputy science director said.
Richard A. Moscicki, deputy center director for science operations at the Food and Drug Administration’s Center for Drug Evaluation and Research, said a Sept. 13 public workshop on the regulatory use of real-world evidence marked an important step in the progression from discourse to action. “This becomes a critical point in that discussion,” he said at the workshop.
The push toward greater use of real-world evidence has the potential to save both time and money to...
For more stories, analysis and expertiseOR Request Trial